These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17138644)

  • 1. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle.
    Boonyaratanakornkit V; McGowan E; Sherman L; Mancini MA; Cheskis BJ; Edwards DP
    Mol Endocrinol; 2007 Feb; 21(2):359-75. PubMed ID: 17138644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.
    Boonyaratanakornkit V; Bi Y; Rudd M; Edwards DP
    Steroids; 2008 Oct; 73(9-10):922-8. PubMed ID: 18321550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
    Skildum A; Faivre E; Lange CA
    Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases.
    Boonyaratanakornkit V; Scott MP; Ribon V; Sherman L; Anderson SM; Maller JL; Miller WT; Edwards DP
    Mol Cell; 2001 Aug; 8(2):269-80. PubMed ID: 11545730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
    McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
    Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
    Faivre EJ; Daniel AR; Hillard CJ; Lange CA
    Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones.
    Boonyaratanakornkit V; Edwards DP
    Essays Biochem; 2004; 40():105-20. PubMed ID: 15242342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways.
    Edwards DP; Wardell SE; Boonyaratanakornkit V
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):173-86. PubMed ID: 12650714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
    Salatino M; Beguelin W; Peters MG; Carnevale R; Proietti CJ; Galigniana MD; Vedoy CG; Schillaci R; Charreau EH; Sogayar MC; Elizalde PV
    Oncogene; 2006 Dec; 25(59):7723-39. PubMed ID: 16799639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interaction of the Krüppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells.
    Zhang D; Zhang XL; Michel FJ; Blum JL; Simmen FA; Simmen RC
    Endocrinology; 2002 Jan; 143(1):62-73. PubMed ID: 11751593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
    Kawprasertsri S; Pietras RJ; Marquez-Garban DC; Boonyaratanakornkit V
    Cancer Lett; 2016 May; 374(2):279-91. PubMed ID: 26892043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of ZK 230211--A type III progesterone receptor antagonist with enhanced antiproliferative properties.
    Afhüppe W; Beekman JM; Otto C; Korr D; Hoffmann J; Fuhrmann U; Möller C
    J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):45-55. PubMed ID: 20043998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
    Shen T; Horwitz KB; Lange CA
    Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
    Faivre EJ; Lange CA
    Mol Cell Biol; 2007 Jan; 27(2):466-80. PubMed ID: 17074804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
    Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
    Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
    Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
    Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.